http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004337268-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b07dcf2402d54dbbd76b479a3053dafb
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01T1-161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21K5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21H5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2003-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94dd4244822a0f56afdff0bdd6dbe787
publicationDate 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2004337268-A
titleOfInvention Antibody-based neutron capture therapy device using monoclonal antibody
abstract An object of the present invention is to provide an antibody-based neutron capture using a monoclonal antibody capable of destroying tumor cells and leaving no damage to normal cells by controlling the amount of emitted radiation. A treatment device is provided. Kind Code: A1 A tumor cell is measured using a PET device, a CT device, and an MRI device. A monoclonal antibody is used as an antibody. The monoclonal antibody is impregnated with boron to bind to the tumor cell. When a thermal neutron beam is irradiated from the external neutron beam generator 1 toward the target, boron causes a nuclear reaction to emit radiation to the tumor cells, thereby destroying only the tumor cells. [Selection diagram] Fig. 1
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020122064-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104174121-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111068186-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102985981-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111068186-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011185600-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018080290-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104174121-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014115122-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012014671-A1
priorityDate 2003-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359967

Total number of triples: 40.